RecruitingCalcium Phosphate Kidney Stones
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Eligible age
21–99 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.
Sponsor: University of Texas Southwestern Medical Center
You may qualify if…
- ✓ \- Calcium Phosphate stone formers
You may not qualify if…
- ✕ History of recurrent urinary tract infections
- ✕ Chronic diarrhea
- ✕ Estimated Glomerular Filtration Rate (eGFR) \< 45 ml/min/1.73 m2
- ✕ History of primary hyperparathyroidism
- ✕ Hypokalemia
- ✕ Hyperkalemia
- ✕ Pregnancy
Where it's recruiting
Texas
Dallas
Source: ClinicalTrials.gov · NCT06003348 · last updated 2026-06-02